Showing 1 - 10 of 18 for "" with applied filters
19 June 2025 by
In April 2024, the China Securities Regulatory Commission ("CSRC") issued five cooperation measures with Hong Kong regarding the capital markets to support leading mainland companies to list in Hong Kong. In October 2024, the Securities and Futures Commission of Hong Kong ("SFC") and the Stock Exchange of Hong Kong Limited ("SEHK") issued the Joint Statement on Optimizing the Timetable of the Examination and Approval Process for New Listing Applications, which sets up a "fast examination and approval channel" for eligible A-share listed companies whose valuation is above RMB 10 billion. Under the support and guidance of relevant policies, since the second half of 2024, a large number of A-share listed companies have been preparing to issue H shares for listing in Hong Kong.
20 January 2025 by
China’s pharmaceutical industry is witnessing a notable surge in “pipeline spin-off projects”, a model commonly referred to as the "Spin-off-NewCo" or "SON" model.
14 November 2024 by
Han Kun Releases 2022-2023 Fund Practice Data Analysis Report
25 October 2024 by
The National Financial Regulatory Administration (“NFRA”) issued the Administrative Measures for Syndicated Loan Business (“Administrative Measures”) on 12 October 2024, which will take effect from 1 November 2024 and shall amend and replace the Guidelines on Syndicated Loan Business issued by the China Banking Regulatory Commission on 1 August 2011 (the “Business Guidelines”).
11 September 2024 by
On September 8, 2024, the Ministry of Commerce, together with the National Health Commission and the National Medical Products Administration publicly issued the Notice on Carrying Out Pilot Programs to Expand Opening-Up in the Healthcare Sector
30 July 2024 by
Onshore Transactions Continued their Upward Trend while VIE Structure Lost Luster for Offshore Transactions
29 May 2024 by
Han Kun advises on JD.com, Inc.'s US$ 2.0 billion convertible senior notes offering
06 March 2024 by
Han Kun provides data compliance counsel to Lucas GC's listing on Nasdaq
05 January 2024 by
Barely a week ago on December 29, 2023, China’s legislative body passed and President Xi Jinping signed into law the newly revised Company Law, effective from July 1, 2024 (the “New Law”).
04 January 2024 by
Driven by the passion and belief, and fraught with various risks and challenges, the research and development of innovative drugs and medical devices is a journey that’s never easy.
